Supernus Pharmaceuticals (SUPN) Share-based Compensation Growth (3y) (2014 - 2026)
Supernus Pharmaceuticals (SUPN) Share-based Compensation Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 10.35% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 40.57% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 67.91% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -28.57% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 12.76% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 20.51% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 17.07% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 37.54% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 18.39% |
| 10 | Supernus Pharmaceuticals | 2.63 Bn | 2.24 Bn | - | 10.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.38% |
| Dec 31, 2025 | 31.33% |
| Sep 30, 2025 | 16.22% |
| Jun 30, 2025 | 20.44% |
| Mar 31, 2025 | 26.09% |
| Dec 31, 2024 | 23.66% |
| Sep 30, 2024 | 23.98% |
| Jun 30, 2024 | 6.16% |
| Mar 31, 2024 | 10.50% |
| Dec 31, 2023 | 27.34% |
| Sep 30, 2023 | 20.83% |
| Jun 30, 2023 | 7.05% |
| Mar 31, 2023 | 16.50% |
| Dec 31, 2022 | 5.56% |
| Sep 30, 2022 | 8.40% |
| Jun 30, 2022 | 2.23% |
| Mar 31, 2022 | 6.98% |
| Dec 31, 2021 | 10.50% |
| Sep 30, 2021 | 15.75% |
| Jun 30, 2021 | 21.30% |